Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Dopamine in Parkinson's disease
Saad Latif, Muhammad Jahangeer, Dure Maknoon Razia, et al.
Clinica Chimica Acta (2021) Vol. 522, pp. 114-126
Closed Access | Times Cited: 215
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications
Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101994-101994
Closed Access | Times Cited: 62
Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
Zhenqi Yang, Yong Zou, Lifeng Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3841-3841
Open Access | Times Cited: 43
Sexually dimorphic dopaminergic circuits determine sex preference
Anqi Wei, Anran Zhao, Chaowen Zheng, et al.
Science (2025) Vol. 387, Iss. 6730
Closed Access | Times Cited: 5
Structures of the human dopamine D3 receptor-Gi complexes
Peiyu Xu, Sijie Huang, Chunyou Mao, et al.
Molecular Cell (2021) Vol. 81, Iss. 6, pp. 1147-1159.e4
Open Access | Times Cited: 71
Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system
Danko Jeremic, Irene Sánchez‐Rodríguez, Lydia Jiménez‐Díaz, et al.
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107808-107808
Open Access | Times Cited: 65
The Signaling and Pharmacology of the Dopamine D1 Receptor
Jace Jones-Tabah, Hanan Mohammad, Emma G. Paulus, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 41
2-Phenethylamines in Medicinal Chemistry: A Review
Carlos T. Nieto, Alejandro Manchado, Leland Belda, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 855-855
Open Access | Times Cited: 33
Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
Pratik Chakraborty, Abhijit Dey, Abilash Valsala Gopalakrishnan, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101838-101838
Closed Access | Times Cited: 23
Structural genomics of the human dopamine receptor system
Peiyu Xu, Sijie Huang, B. Krumm, et al.
Cell Research (2023) Vol. 33, Iss. 8, pp. 604-616
Open Access | Times Cited: 23
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 13
Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
K. Kawahata, David I. Finkelstein, Kohji Fukunaga
Receptors (2024) Vol. 3, Iss. 2, pp. 155-181
Open Access | Times Cited: 12
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
Béla Kiss, I. Laszlovszky, Balázs Krámos, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 104-104
Open Access | Times Cited: 50
Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
Allen P. F. Chen, Lu Chen, Thomas A. Kim, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 647-647
Open Access | Times Cited: 42
History of the dopamine hypothesis of antipsychotic action
Mary V. Seeman
World Journal of Psychiatry (2021) Vol. 11, Iss. 7, pp. 355-364
Open Access | Times Cited: 40
Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review
Maria Rosaria Melis, Fabrizio Sanna, Antonio Argiolas
Brain Sciences (2022) Vol. 12, Iss. 7, pp. 826-826
Open Access | Times Cited: 35
Declining locus coeruleus–dopaminergic and noradrenergic modulation of long-term memory in aging and Alzheimer’s disease
Martin J. Dahl, Agnieszka Kulesza, Markus Werkle‐Bergner, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105358-105358
Open Access | Times Cited: 20
Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
Stuart Isaacson, Robert A. Hauser, Rajesh Pahwa, et al.
Clinical Parkinsonism & Related Disorders (2023) Vol. 9, pp. 100212-100212
Open Access | Times Cited: 18
A review of MPTP-induced parkinsonism in adult zebrafish to explore pharmacological interventions for human Parkinson’s disease
E. E. Bagwell, Jessica Larsen
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Regulation of neuronal circHomer1 biogenesis by PKA/CREB/ERK-mediated pathways and effects of glutamate and dopamine receptor blockade.
Nikolaos Mellios, Grigorios Papageorgiou, Victor Gorgievski, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 5
Expression Profiles of Dopamine-Related Genes and miRNAs Regulating Their Expression in Breast Cancer
Tomasz Sirek, Agata Sirek, Przemysław Borawski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6546-6546
Open Access | Times Cited: 5
PDE10A Inhibitors—Clinical Failure or Window Into Antipsychotic Drug Action?
Frank S. Menniti, Thomas A. Chappie, Christopher J. Schmidt
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 34
Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
Luca Magistrelli, Marco Ferrari, Alessia Furgiuele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3781-3781
Open Access | Times Cited: 32
Circadian clock organization in the retina: From clock components to rod and cone pathways and visual function
Jacob D. Bhoi, Manvi Goel, Christophe Ribelayga, et al.
Progress in Retinal and Eye Research (2022) Vol. 94, pp. 101119-101119
Open Access | Times Cited: 25
Neuropharmacological Effects of Terpenoids on Preclinical Animal Models of Psychiatric Disorders: A Review
Tamanna Jahan Mony, Fazle Elahi, Ji Woong Choi, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1834-1834
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top